No abstract available
MeSH terms
-
Adult
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Clinical Trials as Topic
-
Dermatologic Agents / adverse effects*
-
Female
-
Humans
-
Interleukin-17 / antagonists & inhibitors
-
Interleukin-17 / immunology
-
Male
-
Middle Aged
-
Pharmacovigilance*
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Severity of Illness Index
-
Treatment Outcome
-
Urinary Tract Infections / chemically induced
-
Urinary Tract Infections / epidemiology*
-
Urinary Tract Infections / immunology
-
Young Adult
Substances
-
Antibodies, Monoclonal, Humanized
-
Dermatologic Agents
-
Interleukin-17
-
ixekizumab